A Retrospective Study of Blinatumomab Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) for Patients with Relapsed and Refractory ALL

被引：0
|
作者：
Salhotra, Amandeep
Yang, Dongyun
Mokhtari, Sally
Mei, Matthew
Aribi, Ahmed
Ali, Haris
Al Malki, Monzr M.
Sandhu, Karamjeet S.
Khaled, Samer K.
Budde, Lihua E.
O'Donnell, Margaret
Snyder, David S.
Forman, Stephen J.
Marcucci, Guido
Pullarkat, Vinod
Nakamura, Ryotaro
Stein, Anthony S.
机构：
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2019年 / 25卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
131
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Outcomes of Allogeneic Hematopoietic Cell Transplantation after Salvage Therapy with Blinatumomab in Patients with Relapsed/Refractory Acute Lymphoblastic Leukemia
    Salhotra, Amandeep
    Yang, Dongyun
    Mokhtari, Sally
    Al Malki, Monzr M.
    Ali, Haris
    Sandhu, Karamjeet S.
    Aribi, Ahmed
    Khaled, Samer
    Mei, Matthew
    Budde, Elizabeth
    Snyder, David
    Cao, Thai
    Spielberger, Ricardo
    Marcucci, Guido
    Pullarkat, Vinod
    Forman, Stephen J.
    Nakamura, Ryotaro
    Stein, Anthony
    Aldoss, Ibrahim
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (06) : 1084 - 1090
  • [2] A Retrospective Study of Venetoclax-Based Salvage Regimen As a Bridge to Allogeneic Hematopoietic Cell Transplantation (HCT) in High-Risk Acute Myeloid Leukemia (AML) Patients
    Sandhu, Karamjeet S.
    Aldoss, Ibrahim
    Yang, Dongyun
    Mokhtari, Sally
    Mei, Matthew
    Aribi, Ahmed
    Ali, Haris
    Al Malki, Monzr M.
    Salhotra, Amandeep
    Khaled, Samer K.
    Budde, Lihua E.
    Sun, Weili
    O'Donnell, Margaret
    Snyder, David S.
    Forman, Stephen J.
    Stein, Anthony S.
    Marcucci, Guido
    Nakamura, Ryotaro
    Pullarkat, Vinod
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2019, 25 (03)
  • [3] Clofarabine Salvage Therapy Prior To Allogeneic Hematopoietic Stem Cell Transplantation (HCT) In Patients With Relapsed Or Refractory Acute Leukemia
    Serrano, Josefina
    Buenasmananas, Diana
    Herrera, P.
    Amigo, Mari Luz
    Calabuig, Marisa
    Martin, Eusebio
    Vidriales, Maria Belen
    de la Fuente, Adolfo
    Santero, M.
    Negri, Silvia
    Gonzalez-Campos, Jose
    Albo, Carmen
    Gonzalez, Sonia
    Rifon, Jose J.
    Viguria, M. Cruz
    Garcia-Gutierrez, V.
    Martin, Carmen
    Sanchez-Garcia, Joaquin
    BLOOD, 2013, 122 (21)
  • [4] Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma
    Wang, Jing-Shi
    Wang, Zhao
    Wang, Yi-Ni
    Wu, Lin
    Fu, Li
    Wei, Na
    INDIAN JOURNAL OF HEMATOLOGY AND BLOOD TRANSFUSION, 2015, 31 (04) : 426 - 433
  • [5] Allogeneic Hematopoietic Stem Cell Transplantation: A Salvage Treatment for Relapsed or Refractory Lymphoma
    Jing-Shi Wang
    Zhao Wang
    Yi-Ni Wang
    Lin Wu
    Li Fu
    Na Wei
    Indian Journal of Hematology and Blood Transfusion, 2015, 31 : 426 - 433
  • [6] Clofarabine Salvage Therapy Prior to Allogeneic Hematopoietic Cell Transplantation in Patients with Relapsed or Refractory AML - Interim Results of the Bridge Trial
    Middeke, Jan Moritz
    Parmentier, Stefani
    Alakel, Nael
    Schaich, Markus
    Thiede, Christian
    Platzbecker, Uwe
    Roellig, Christoph
    Haenel, Mathias
    Stuhler, Gernot
    Morgner, Anke
    Eulenstein, Uta
    Ehninger, Gerhard
    Bornhaeuser, Martin
    Schetelig, Johannes
    BLOOD, 2012, 120 (21)
  • [7] Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    Middeke, J. M.
    Herbst, R.
    Parmentier, S.
    Bug, G.
    Haenel, M.
    Stuhlers, G.
    Schaefer-Eckart, K.
    Roester, W.
    Klein, S.
    Bethge, W.
    Bitz, U.
    Buettner, B.
    Knoth, H.
    Alakel, N.
    Schaich, M.
    Morgner, A.
    Kramer, M.
    Sockel, K.
    von Bonin, M.
    Stoelzel, F.
    Platzbecker, U.
    Roellig, C.
    Thiede, C.
    Ehninger, G.
    Bornhaeuser, M.
    Schetelig, J.
    LEUKEMIA, 2016, 30 (02) : 261 - 267
  • [8] Clofarabine salvage therapy before allogeneic hematopoietic stem cell transplantation in patients with relapsed or refractory AML: results of the BRIDGE trial
    J M Middeke
    R Herbst
    S Parmentier
    G Bug
    M Hänel
    G Stuhler
    K Schäfer-Eckart
    W Rösler
    S Klein
    W Bethge
    U Bitz
    B Büttner
    H Knoth
    N Alakel
    M Schaich
    A Morgner
    M Kramer
    K Sockel
    M von Bonin
    F Stölzel
    U Platzbecker
    C Röllig
    C Thiede
    G Ehninger
    M Bornhäuser
    J Schetelig
    Leukemia, 2016, 30 : 261 - 267
  • [9] Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation
    Ye, Peipei
    Pei, Renzhi
    Jin, Jie
    Sun, Jie
    Li, Kongfei
    Cao, Junjie
    Zhou, Dandan
    Lu, Ying
    ANNALS OF HEMATOLOGY, 2019, 98 (09) : 2073 - 2080
  • [10] Modified cladribine, cytarabine, and G-CSF as a salvage regimen in patients with relapsed/refractory acute myeloid leukemia: a bridge to myeloablative allogeneic hematopoietic stem cell transplantation
    Peipei Ye
    Renzhi Pei
    Jie Jin
    Jie Sun
    Kongfei Li
    Junjie Cao
    Dandan Zhou
    Ying Lu
    Annals of Hematology, 2019, 98 : 2073 - 2080
12345